Get the Stockscreener App
3.60
16.13%
0.50
After Hours:
3.60
Xenetic Biosciences Inc stock is traded at $3.60, with a volume of 49,291.
It is up +16.13% in the last 24 hours and up +29.03% over the past month.
Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors.
See More
Previous Close:
$3.10
Open:
$3.06
24h Volume:
49,291
Relative Volume:
0.66
Market Cap:
$5.55M
Revenue:
$2.54M
Net Income/Loss:
$-4.13M
P/E Ratio:
-1.3091
EPS:
-2.75
Net Cash Flow:
$-4.11M
1W Performance:
+17.25%
1M Performance:
+29.03%
6M Performance:
+0.28%
1Y Performance:
-6.37%
1-Day Range:
$3.06
$3.70
1-Week Range:
$2.90
$3.70
52-Week Range:
$2.20
$5.2683
Xenetic Biosciences Inc Stock (XBIO) Company Profile
Name
Xenetic Biosciences Inc
Sector
Industry
Phone
781-778-7720
Address
945 CONCORD ST., FRAMINGHAM, MA
Compare XBIO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XBIO
Xenetic Biosciences Inc
|
3.60 | 4.60M | 2.54M | -4.13M | -4.11M | -2.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Xenetic Biosciences Inc Stock (XBIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-08-20 | Initiated | Maxim Group | Buy |
Xenetic Biosciences Inc Stock (XBIO) Latest News
Automated trading signals detected on Xenetic Biosciences Inc.Quarterly Portfolio Review & Weekly High Potential Alerts - Newser
Is Xenetic Biosciences Inc. building a consolidation baseIPO Watch & Weekly Chart Analysis and Trade Guides - Newser
What institutional flow reveals about Xenetic Biosciences Inc.Weekly Trend Summary & High Return Trade Opportunity Guides - Newser
Will Xenetic Biosciences Inc. continue its uptrendWeekly Trend Summary & Advanced Swing Trade Entry Alerts - Newser
What does recent volatility data suggest for Xenetic Biosciences Inc.Weekly Stock Report & High Accuracy Trade Alerts - Newser
Will Xenetic Biosciences Inc. price bounce be sustainableWeekly Gains Report & Free Community Consensus Stock Picks - Newser
Does Xenetic Biosciences Inc. show high probability of reboundJuly 2025 Trends & Stock Portfolio Risk Management - Newser
Can trapped investors hope for a rebound in Xenetic Biosciences Inc.Quarterly Trade Report & Verified Momentum Stock Alerts - Newser
Visual analytics tools that track Xenetic Biosciences Inc. performanceWeekly Profit Recap & Verified Momentum Stock Watchlist - Newser
Will Xenetic Biosciences Inc. stock go up soon2025 Analyst Calls & Fast Entry High Yield Stock Tips - Newser
How to build a dashboard for Xenetic Biosciences Inc. stockWeekly Earnings Recap & Real-Time Market Sentiment Alerts - Newser
Understanding Xenetic Biosciences Inc.’s price movementGDP Growth & Pattern Based Trade Signal System - Newser
What Fibonacci levels say about Xenetic Biosciences Inc. reboundWeekly Stock Analysis & Weekly Setup with High ROI Potential - Newser
Chart based exit strategy for Xenetic Biosciences Inc.2025 Performance Recap & Consistent Income Trade Ideas - Newser
Custom watchlist performance reports with Xenetic Biosciences Inc.2025 Analyst Calls & Low Risk High Reward Ideas - Newser
Sentiment analysis tools applied to Xenetic Biosciences Inc.CEO Change & Long-Term Safe Investment Plans - Newser
Intraday pattern recognizer results for Xenetic Biosciences Inc.July 2025 Update & AI Optimized Trading Strategy Guides - Newser
Visualizing Xenetic Biosciences Inc. stock with heatmaps2025 Price Targets & High Accuracy Trade Alerts - Newser
Forecasting Xenetic Biosciences Inc. price range with options dataWeekly Investment Recap & Weekly Return Optimization Plans - Newser
Leading vs lagging indicators on Xenetic Biosciences Inc. performanceMarket Growth Report & Risk Managed Trade Strategies - Newser
Price momentum metrics for Xenetic Biosciences Inc. explained2025 Major Catalysts & Growth Oriented Trading Recommendations - Newser
Live market analysis of Xenetic Biosciences Inc.2025 Institutional Moves & Consistent Profit Trade Alerts - Newser
Multi factor analysis applied to Xenetic Biosciences Inc.Market Risk Report & Low Volatility Stock Recommendations - Newser
Xenetic Biosciences Inc. stock trend outlook and recovery pathPortfolio Growth Summary & Fast Gaining Stock Strategy Reports - Newser
Xenetic Biosciences Inc.’s volatility index tracking explainedTrade Entry Summary & Verified Short-Term Trading Plans - Newser
How to track smart money flows in Xenetic Biosciences Inc.2025 Price Momentum & Weekly High Return Stock Forecasts - Newser
Should you hold or exit Xenetic Biosciences Inc. nowBuy Signal & Expert Curated Trade Ideas - Newser
What recovery options are there for Xenetic Biosciences Inc.Trend Reversal & Reliable Entry Point Trade Alerts - Newser
Xenetic Biosciences Inc Stock (XBIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):